Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets
Related Experiment Video
Updated: May 25, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Lok-To Sham1, Ho-Ching T Tsui, Adrian D Land
1Department of Biology, Indiana University Bloomington, Bloomington, IN 47405, United States.
Abstract:
Streptococcus pneumoniae is a serious human respiratory pathogen that has the capacity to evade capsule-based vaccines and to develop multidrug antibiotic resistance. This review summarizes recent advances in understanding the mechanisms and regulation of peptidoglycan (PG) biosynthesis that result in ellipsoid-shaped, ovococcus Streptococcus cells. New results support a two-state model for septal and peripheral PG synthesis at mid-cell, involvement of essential cell division proteins in PG remodeling, and mid-cell localization of proteins that organize PG biosynthesis and that form the protein translocation apparatus. PG biosynthesis proteins have already turned up as promising vaccine candidates and targets of antibiotics. Properties of several recently characterized proteins that mediate or regulate PG biosynthesis suggest a source of additional targets for therapies against pneumococcus.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Microorganisms in Medicine and Therapeutics
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Peptidoglycan Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing

